58 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABBV AbbVie Inc. $95.37 $144.42B N/A
Article Searches
The Zacks Analyst Blog Highlights: Microsoft, Home Depot, AbbVie, Disney and Host Hotels http://www.zacks.com/stock/news/509524/the-zacks-analyst-blog-highlights-microsoft-home-depot-abbvie-disney-and-host-hotels?cid=CS-ZC-FT-press_releases-509524 Sep 09, 2019 - The Zacks Analyst Blog Highlights: Microsoft, Home Depot, AbbVie, Disney and Host Hotels
Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio http://www.zacks.com/stock/news/512942/why-abbvie-abbv-is-a-top-dividend-stock-for-your-portfolio?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-512942 Sep 11, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
4 Big Drugmakers Boasting Impressive Oncology Pipelines http://www.zacks.com/stock/news/513001/4-big-drugmakers-boasting-impressive-oncology-pipelines?cid=CS-ZC-FT-analyst_blog|industry_focus-513001 Sep 11, 2019 - We discuss four pharma giants, which possess the industry's strongest oncology pipeline portfolios.
Anxious About AbbVie? Here Are 4 Things You Should Know https://www.fool.com/investing/2019/09/12/anxious-about-abbvie-here-are-4-things-you-should.aspx?source=iedfolrf0000001 Sep 12, 2019 - The situation for AbbVie probably isn't nearly as bad as you think it is.
Dividend Growth ETFs for Long Term Investors http://www.zacks.com/stock/news/517301/dividend-growth-etfs-for-long-term-investors?cid=CS-ZC-FT-etf_news_and_commentary-517301 Sep 13, 2019 - Dividend growth ETFs hold companies with solid balance sheets and rising earnings.
Here is Why Growth Investors Should Buy AbbVie (ABBV) Now http://www.zacks.com/stock/news/542551/here-is-why-growth-investors-should-buy-abbvie-abbv-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-542551 Sep 30, 2019 - AbbVie (ABBV) could produce exceptional returns because of its solid growth attributes.
AbbVie (ABBV) Gets FDA Nod for Label Expansion of HCV Drug http://www.zacks.com/stock/news/539107/abbvie-abbv-gets-fda-nod-for-label-expansion-of-hcv-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-539107 Sep 27, 2019 - AbbVie (ABBV) gets FDA approval for the label expansion of Mavyret.
Top Stock Reports for AbbVie, Starbucks & Phillips 66 http://www.zacks.com/research-daily/544529/top-stock-reports-for-abbvie-starbucks-phillips-66?cid=CS-ZC-FT-research_daily-544529 Oct 01, 2019 - Top Stock Reports for AbbVie, Starbucks & Phillips 66
Top Ranked Income Stocks to Buy for October 2nd http://www.zacks.com/commentary/545738/top-ranked-income-stocks-to-buy-for-october-2nd?cid=CS-ZC-FT-zacks_#1_rank_additions-545738 Oct 02, 2019 - Top Ranked Income Stocks to Buy for October 2nd
3 Top Dividend Stocks to Buy Right Now https://www.fool.com/investing/2019/10/06/3-top-dividend-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 Oct 06, 2019 - With high yields and solid growth prospects, these companies deserve income investors' attention.

Pages: 123456

Page 1>